200,000+ products from a single source!

sales@angenechem.com

Home > Fluorides > 148451-96-1

148451-96-1

148451-96-1 | L-Tryptophan, N-acetyl-, [3,5-bis(trifluoromethyl)phenyl]methyl ester

CAS No: 148451-96-1 Catalog No: AG001KXP MDL No:

Product Description

Catalog Number:
AG001KXP
Chemical Name:
L-Tryptophan, N-acetyl-, [3,5-bis(trifluoromethyl)phenyl]methyl ester
CAS Number:
148451-96-1
Molecular Formula:
C22H18F6N2O3
Molecular Weight:
472.3803
IUPAC Name:
[3,5-bis(trifluoromethyl)phenyl]methyl (2S)-2-acetamido-3-(1H-indol-3-yl)propanoate
InChI:
InChI=1S/C22H18F6N2O3/c1-12(31)30-19(8-14-10-29-18-5-3-2-4-17(14)18)20(32)33-11-13-6-15(21(23,24)25)9-16(7-13)22(26,27)28/h2-7,9-10,19,29H,8,11H2,1H3,(H,30,31)/t19-/m0/s1
InChI Key:
BYYQYXVAWXAYQC-IBGZPJMESA-N
SMILES:
CC(=O)NC(C(=O)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F)Cc1c[nH]c2c1cccc2

Properties

Complexity:
677  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
472.122g/mol
Formal Charge:
0
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
472.387g/mol
Monoisotopic Mass:
472.122g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
71.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.7  

Literature

Title Journal
Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation. European journal of pharmacology 20120605
The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines. Investigational new drugs 20120401
Role of tachykinin and neurokinin receptors in the regulation of ovine omasal contractions. Regulatory peptides 20120110
Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells. Cardiovascular research 20111201
Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies. Journal of medicinal chemistry 20110414
Selective nasal allergen provocation induces substance P-mediated bronchial hyperresponsiveness. American journal of respiratory cell and molecular biology 20110401
Spinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla. Neuroscience 20101229
Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines. Journal of medicinal chemistry 20100812
NK-1 receptor is involved in the decreased movement in a rat chronic acid reflux oesophagitis model. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100501
The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety. Bioorganic & medicinal chemistry 20091015
Bronchoconstriction induced by hyperventilation with humidified hot air: role of TRPV1-expressing airway afferents. Journal of applied physiology (Bethesda, Md. : 1985) 20090601
Functional type I vanilloid receptor expression by substantia gelatinosa neurons of trigeminal subnucleus caudalis in mice. Neuroscience letters 20090320
Substance P stimulates CFTR-dependent fluid secretion by mouse tracheal submucosal glands. Pflugers Archiv : European journal of physiology 20081101
The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists. Journal of medicinal chemistry 20081023
NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Investigational new drugs 20080401
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists. Journal of medicinal chemistry 20080313
Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138. Investigative ophthalmology & visual science 20070601
Vanilloid receptor-1 (TRPV1)-dependent activation of inhibitory neurotransmission in spinal substantia gelatinosa neurons of mouse. Pain 20070501
Paradoxical effect of salbutamol in a model of acute organophosphates intoxication in guinea pigs: role of substance P release. American journal of physiology. Lung cellular and molecular physiology 20070401
Involvement of TRPV1-dependent and -independent components in the regulation of vagally induced contractions in the mouse esophagus. European journal of pharmacology 20070205
Substance P up-regulates matrix metalloproteinase-1 and down-regulates collagen in human lung fibroblast. Experimental lung research 20070101
Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea. Allergology international : official journal of the Japanese Society of Allergology 20061201
The prokinetic-like activity of ghrelin in rat isolated stomach is mediated via cholinergic and tachykininergic motor neurones. European journal of pharmacology 20060821
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Role of substance P in allergic nasal symptoms in rats. European journal of pharmacology 20060217
Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain 20050801
Prediction of genotoxicity of chemical compounds by statistical learning methods. Chemical research in toxicology 20050601
Substance P promotes sleep in the ventrolateral preoptic area of rats. Brain research 20041203
Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience 20041110
PET evaluation of the uptake of N-[11C]methyl CP-643,051, an NK1 receptor antagonist, in the living porcine brain. Nuclear medicine and biology 20040801
Histamine H3 receptors regulate vascular permeability changes in the skin of mast cell-deficient mice. International immunopharmacology 20031101
Involvement of spinal neurokinin-1 receptors in the maintenance but not induction of carrageenan-induced thermal hyperalgesia in the rat. Brain research bulletin 20031015
T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis. Blood 20030915
Tachykinins mediate non-adrenergic, non-cholinergic excitatory neurotransmission to the hamster ileum via NK1 and NK2 receptors. Life sciences 20030829
A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death. Cell death and differentiation 20020801
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
Characterization of the mechanism underlying stonustoxin-mediated relaxant response in the rat aorta in vitro. Biochemical pharmacology 20020315
Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist. Pain 20020201
Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)2 deduced from two-dimensional 1H-NMR and conformational energy calculations is related to its affinity for NK1-receptor. Journal of peptide science : an official publication of the European Peptide Society 20010601
Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor. The Journal of biological chemistry 19940304

Related Products

© 2019 Angene International Limited. All rights Reserved.